Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection

Arthritis and Rheumatology

Volumn 66, Issue 2, 2014, Pages 319-326

  Chopra, Arvind ^a   Saluja, Manjit ^a   Venugopalan, Anuradha ^a  

^a Center for Rheumatic Diseases   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 13; INTERLEUKIN 6; MELOXICAM; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE RESPONSE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOLOGY; RURAL POPULATION; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; UPPER ABDOMINAL PAIN; VIRUS INFECTION; VISUAL ANALOG SCALE; VOMITING;

ACUTE DISEASE; ALPHAVIRUS INFECTIONS; ARTHRITIS; CHLOROQUINE; CYTOKINES; DISEASE MANAGEMENT; EPIDEMICS; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; PAIN MEASUREMENT; THIAZINES; THIAZOLES; TREATMENT OUTCOME;

EID: 84896284300     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38221     Document Type: Article

References (23)

1. Lahariya C, Pradhan SK. Emergence of chikungunya virus in Indian subcontinent after 32 years: a review. J Vect Borne Dis 2006;43: 151-60.
2. Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS, Sarangan G, et al. Chikungunya: a potentially emerging epidemic? PLoS Negl Trop Dis 2010;4:e623.
3. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 2012;140: 842-50.
4. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 2008;58: 2921-2.
5. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36: 729-40.
6. Chopra A, Saluja M. Validation and usefulness of Indian version (CRD Pune) health assessment questionnaire: drug trials, community practice and COPCORD Bhigwan population study (1994-2012). Indian J Rheumatol 2012;7: 74-82.
7. Joshi VL, Chopra A. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model. J Rheumatol 2009;36: 614-22.
8. Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H, et al. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm 2010;2010: 158514.
9. Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis: an open pilot study. S Afr Med J 1984;66: 217-8.
10. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis 2003;3: 722-7.
11. Ozden S, Lucas-Hourani M, Ceccaldi PE, Basak A, Valentine M, Benjannet S, et al. Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J Biol Chem 2008;8: 21899-908.
12. Tang BL. The cell biology of Chikungunya virus infection. Cell Microbiol 2012;14: 1354-63.
13. Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A. Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus 2006;15: 268-75.
14. US National Institutes of Health. CuraChik: a trial of the efficacy and safety of chloroquine as therapeutic treatment of Chikungunya. October 2008. ClinicalTrials.gov URL: http://clinicaltrials. gov/ct2/show/NCT00391313.
15. De Lamballerie X, Boisson V, Reynier JC, Ernault S, Charrel RN, Fiahault A, et al. On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis 2008;8: 837-9.
16. Padmakumar B, Jayan JB, Menon RM, Krishnankutty B, Payippallil R, Nisha RS. Comparative evaluation of four therapeutic regimens in Chikungunya arthritis: a prospective randomized parallel group study. Indian J Rheumatol 2009;4;94-101.
17. Pandya S. Methotrexate and hydroxychloroquine combination therapy in chronic Chikungunya arthritis: a 16 week study. Indian J Rheumatol 2008;3: 93-7.
18. Chopra A, Venugopalan A. Persistent rheumatic musculoskeletal pain and disorders at one year post-Chikungunya epidemic in south Maharashtra: a rural community based observational study with special focus on naive persistent rheumatic musculoskeletal cases and selected cytokine express. Indian J Rheumatol 2011;6: 5-11.
19. Tokayer A, Carsons SE, Chokshi B, Santiago-Schwarz F. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity. J Rheumatol 2002;29: 454-61.
20. Couderc T, Chretien F, Schilte C, Disson O, Brugitte M, Guivel-Benhassine F, et al. A mouse model for Chikungunya: young age and inefficient type-1 interferon signaling are risk factors for severe disease. PLoS Pathog 2008;4:e29.
21. Labadie KT, Larcher C, Joubert A, Mannioui B, Delache P, Brochard L, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010;120: 894-906.
22. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P, et al. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 2012;6:e1446.
23. Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses: an overview. Nat Rev Rheumatol 2012;8: 420-9.